
    
      This retrospective, observational cohort analysis will assess medical and pharmacy claims for
      adult patients with type 2 diabetes from the Truven Health MarketScanÂ® Commercial and
      Medicare Supplemental claims databases between 2011 and 2015. Diabetes-related healthcare
      utilization and costs will be measured as a primary outcome. Secondary outcomes include
      all-cause healthcare utilization and costs, major adverse cardiovascular event (MACE)-related
      utilization and costs, and medically attended hypoglycemia events.
    
  